Osaka, Japan

Yuki Ikeda

USPTO Granted Patents = 9 


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Ibaraki, JP (2013 - 2017)
  • Osaka, JP (2016 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Yuki Ikeda: Innovator in Therapeutic Solutions

Introduction

Yuki Ikeda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 9 patents to his name, Ikeda's work reflects a commitment to improving patient outcomes through innovative solutions.

Latest Patents

One of Ikeda's latest patents is a therapeutic drug designed for motor complications in Parkinson's disease. This invention provides a composition and method for treating, improving, suppressing the progression, or preventing motor complications, especially motor fluctuations. The drug comprises tandospirone or a pharmaceutically acceptable salt thereof, which is administered parenterally. This advancement holds promise for enhancing the quality of life for individuals affected by this condition.

Career Highlights

Throughout his career, Yuki Ikeda has worked with notable companies such as Sumitomo Dainippon Pharma Co., Ltd. and Sumitomo Pharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic options in the pharmaceutical industry.

Collaborations

Ikeda has collaborated with esteemed colleagues, including Yasushi Ochiai and Mitsumasa Kurita. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Yuki Ikeda's contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease, highlight his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…